FDA D.I.S.C.O.: L-Glutamine for Sickle Cell Disease
FDA D.I.S.C.O.: L-Glutamine for Sickle Cell Disease
FDA D.I.S.C.O.: Osimertinib for Non-Small Cell Lung Cancer
FDA D.I.S.C.O.: Osimertinib for Non-Small Cell Lung Cancer
FDA D.I.S.C.O.: Two Approvals for ALK-Positive Non-Small Cell Lung Cancer
FDA D.I.S.C.O.: Two Approvals for ALK-Positive Non-Small Cell Lung Cancer
FDA D.I.S.C.O.: First Tissue/Site Agnostic Cancer Treatment Approval
FDA D.I.S.C.O.: First Tissue/Site Agnostic Cancer Treatment Approval
FDA D.I.S.C.O.: Avelumab in Merkel Cell Carcinoma
FDA D.I.S.C.O.: Avelumab in Merkel Cell Carcinoma
FDA D.I.S.C.O.: Niraparib in Ovarian Cancer
FDA D.I.S.C.O.: Niraparib in Ovarian Cancer
FDA D.I.S.C.O.: Rucaparib in Ovarian Cancer
FDA D.I.S.C.O.: Rucaparib in Ovarian Cancer
FDA Confirms Leg and Foot Amputation Risk with Diabetes Medicine Canagliflozin
FDA Confirms Leg and Foot Amputation Risk with Diabetes Medicine Canagliflozin
Introducing FDA's Drug Information Soundcast in Clinical Oncology (DISCO)
Introducing FDA's Drug Information Soundcast in Clinical Oncology (DISCO)
Study Examines Effectiveness of Steroid Medication for Sore Throat
Study Examines Effectiveness of Steroid Medication for Sore Throat
FDA Restricts Use of Prescription Codeine and Tramadol Pain Medicines in Children
FDA Restricts Use of Prescription Codeine and Tramadol Pain Medicines in Children
Behind the Black Box: The Dark Side of Big Pharma Research
Behind the Black Box: The Dark Side of Big Pharma Research
Biologics for Inflammatory Bowel Disease: Maximizing Benefits, Avoiding Complications
Biologics for Inflammatory Bowel Disease: Maximizing Benefits, Avoiding Complications
Beyond the Data: Overcoming Barriers to Medication Adherence for Chronic Diseases
Beyond the Data: Overcoming Barriers to Medication Adherence for Chronic Diseases
Overcoming Barriers to Medication Adherence for Chronic Diseases
Overcoming Barriers to Medication Adherence for Chronic Diseases
